Baseline vascular SHRM volume independently predicts worse VFQ-25 composite score after anti-VEGF therapy in nAMD, adding 8.0% incremental variance beyond visual acuity and clinical covariates.
Details: https://www.maxapress.com/article/doi/10.48130/vns-0026-0023
#OCT #NeovascularAMD #AntiVEGF
Baseline vascular SHRM volume independently predicts worse VFQ-25 composite score after anti-VEGF therapy in nAMD, adding 8.0% incremental variance beyond visual acuity and clinical covariates.
Details: https://www.maxapress.com/article/doi/10.48130/vns-0026-0023
#OCT #NeovascularAMD #AntiVEGF